Get the Stockscreener App
2.36
3.67%
-0.09
Alzamend Neuro Inc stock is traded at $2.36, with a volume of 38,847.
It is down -3.67% in the last 24 hours and down -2.07% over the past month.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
See More
Previous Close:
$2.45
Open:
$2.37
24h Volume:
38,847
Relative Volume:
0.32
Market Cap:
$7.41M
Revenue:
-
Net Income/Loss:
$-6.24M
P/E Ratio:
-0.4225
EPS:
-5.5853
Net Cash Flow:
$-8.09M
1W Performance:
-1.67%
1M Performance:
-2.07%
6M Performance:
-60.39%
1Y Performance:
-83.91%
1-Day Range:
$2.36
$2.46
1-Week Range:
$2.27
$2.5562
52-Week Range:
$2.06
$15.21
Alzamend Neuro Inc Stock (ALZN) Company Profile
Name
Alzamend Neuro Inc
Sector
Industry
Phone
844-722-6333
Address
3500 LENOX RD. NE, ATLANTA
Compare ALZN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALZN
Alzamend Neuro Inc
|
2.36 | 9.31M | 0 | -6.24M | -8.09M | -5.5853 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.39 | 107.73B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
654.48 | 62.04B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
475.91 | 62.73B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
836.39 | 51.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.29 | 34.67B | 398.11M | -1.03B | -868.57M | -5.7032 |
Alzamend Neuro Inc Stock (ALZN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-21 | Initiated | Ascendiant Capital Markets | Buy |
Alzamend Neuro Inc Stock (ALZN) Latest News
Predicting Alzamend Neuro Inc. trend using moving averagesQuarterly Trade Review & Accurate Technical Buy Alerts - newser.com
Will Alzamend Neuro Inc. stock pay special dividendsEarnings Recap Summary & Reliable Price Action Trade Plans - newser.com
Alzamend Neuro Inc. stock trend outlook and recovery path2025 Fundamental Recap & Community Driven Trade Alerts - newser.com
Is Alzamend Neuro Inc. stock cheap compared to fundamentalsMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com
How currency fluctuations impact Alzamend Neuro Inc. stockTrend Reversal & Reliable Trade Execution Plans - newser.com
Will Alzamend Neuro Inc. stock outperform growth indexesEarnings Recap Report & AI Enhanced Trading Signals - Fundação Cultural do Pará
Why Alzamend Neuro Inc. stock could rally in 2025Market Risk Summary & Community Supported Trade Ideas - Fundação Cultural do Pará
Will Alzamend Neuro Inc. stock remain a Wall Street favoriteTrade Volume Summary & High Conviction Investment Ideas - Fundação Cultural do Pará
What earnings revisions data tells us about Alzamend Neuro Inc.2025 Market Overview & Technical Pattern Based Signals - newser.com
Will Alzamend Neuro Inc. stock go up soonJuly 2025 EndofMonth & Fast Momentum Entry Tips - newser.com
Is Alzamend Neuro Inc. stock recession proofEarnings Risk Summary & Community Consensus Picks - newser.com
Will Alzamend Neuro Inc. stock rally after Fed decisionsJuly 2025 Earnings & Stepwise Swing Trade Plans - newser.com
Can Alzamend Neuro Inc. stock outperform in 2025 bull marketWeekly Investment Recap & Smart Investment Allocation Tips - newser.com
Historical volatility pattern of Alzamend Neuro Inc. visualizedEarnings Recap Summary & Expert Verified Stock Movement Alerts - newser.com
Multi asset correlation models including Alzamend Neuro Inc.July 2025 Trade Ideas & Daily Stock Momentum Reports - newser.com
Why Alzamend Neuro Inc. stock attracts high net worth investorsJuly 2025 Levels & Weekly High Momentum Picks - newser.com
Is Alzamend Neuro Inc. forming a bottoming base2025 Geopolitical Influence & Smart Money Movement Tracker - newser.com
Is Alzamend Neuro Inc. stock supported by innovation pipelineAnalyst Downgrade & Smart Allocation Stock Tips - newser.com
Will Alzamend Neuro Inc. stock reach all time highs in 2025July 2025 Summary & Risk Managed Investment Signals - newser.com
Can Alzamend Neuro Inc. stock resist sector downturnsWeekly Trend Summary & Risk Controlled Daily Trade Plans - newser.com
What to do if you’re stuck in Alzamend Neuro Inc.Entry Point & Low Risk Entry Point Tips - newser.com
Chart based exit strategy for Alzamend Neuro Inc.Weekly Loss Report & Precise Swing Trade Entry Alerts - newser.com
Alzamend Neuro Inc Stock (ALZN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.28%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):